NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, has launched an investigation to determine whether officers or directors of LHC Group, Inc. (NASDAQ: LHCG) breached their fiduciary duties or violated federal securities laws in connection with the company’s acquisition by Optum, a part of UnitedHealth Group Inc. (NYSE: UNH).
Click here to learn more and get in on the action.
On March 29, 2022, LHC announced that it had entered into an agreement for acquisition by Optum in a deal valued at approximately $5.4 billion. Pursuant to the merger agreement, LHC shareholders will receive $170 in cash for each LHC common share held. The deal is expected to close in the second half of 2022.
Bragar Eagel & Squire fears that the LHC board oversaw an unfair process and ultimately agreed to an inadequate merger deal. Accordingly, the company is reviewing all relevant aspects of the agreement and is committed to ensuring the best possible outcome for LHC shareholders.
If you own shares of LHC and are concerned about the proposed merger, or would like to know more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at [email protected] bespc.com or by phone at (646) 860-9157, or by filling out this contact form. There is no cost or obligation for you.
About Bragar Eagel & Squire, PC:
Bragar Eagel & Squire, PC is a nationally recognized law firm with offices in New York, California and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivatives and other complex litigation before state and federal courts across the country. For more information about the company, please visit www.bespc.com. Lawyer advertisement. Prior results do not guarantee similar results.
Bragar Eagel & Squire, CP
Melissa Fortunato, Esq.
Alexandra Raymond, Esq.